Nicole Scangarella-Oman

17PUBLICATIONS
27CO-AUTHORS
Cellular nervous systemMicrobial geneticsHost-parasite interactionsInfectious agentsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 07, 2026
In vitro activity of gepotidacin against baseline Neisseria gonorrhoeae phenotypes and genotypes recovered from a clinical trial for uncomplicated urogenital gonorrhea (EAGLE-1).

|Aug 06, 2026
Characterization of gepotidacin activity, including in vitro kill kinetics, checkerboard, and PAE/SME testing against gram-positive and gram-negative bacteria.

|Jul 07, 2026
Subgroup Analysis of Pooled Phase 3 Efficacy Data from Two Randomized Trials of Gepotidacin Versus Nitrofurantoin in Uncomplicated Urinary Tract Infections (EAGLE-2 and EAGLE-3) including Participants with Uropathogens Not-Susceptible to Nitrofurantoin.

|Jul 02, 2026
In vitro antibacterial activity of gepotidacin in combination with other antimicrobial agents against Neisseria gonorrhoeae isolates.

|Apr 30, 2026
Determination of frequency of spontaneous resistance for gepotidacin and levofloxacin against a collection of gram-positive and gram-negative organisms.

|Sep 09, 2025
Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including subsets with molecularly characterized resistance mechanisms and genotypes/epidemiological clones, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3).

Nicole E Scangarella-Oman, Deborah L Butler, John Breton

Pageof 3

Frequent Collaborators

3 joint publications

S J Ryan Arends

2 joint publications

Brian D VanScoy

2 joint publications

Sujata M Bhavnani

2 joint publications

Mariana Castanheira